KnowLab
Apr 7, 2023 • Less than a minute read

New paper - a systematic review on antidepressant and antipsychotic drug prescribing and diabetes outcomes

As part of her PhD research, Charlotte led this systematic review to investigate the association between antidepressant or antipsychotic drug prescribing and type 2 diabetes outcomes. It concludes - *Studies of antidepressant and antipsychotic drug prescribing in relation to diabetes outcomes are scarce, with shortcomings and mixed findings. Until further evidence is available, people with diabetes prescribed antidepressants and antipsychotics should receive monitoring and appropriate treatment of risk factors and screening for complications as recommended in general diabetes guidelines.*

Read it at [DOI:10.1016/j.diabres.2023.110649](https://doi.org/10.1016/j.diabres.2023.110649)

Charlotte R.L. Greene, Hanna Ward-Penny, Marianna F. Ioannou, Sarah H. Wild, Honghan Wu, Daniel J. Smith, Caroline A. Jackson. “Antidepressant and antipsychotic drug prescribing and diabetes outcomes: A systematic review of observational studies”. Diabetes Research and Clinical Practice (2023). DOI:10.1016/j.diabres.2023.110649 .

Post by: KnowLab